510(k) Report

510(k) · Cleared

Cleared

Retinadx

K003236510(k) TraditionalCleared Nov 2, 200016-day reviewClass II21 CFR 886.1120

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Regulatory Associates, Inc. · HKI Camera, Ophthalmic, Ac-Powered

Cleared on Nov 2, 2000 after a 16-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Nov 2, 2000
Review
16 days
Class
Class II
Product code
HKI
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K003236Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HKI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HKI device

  1. #1 K253176 TearViewscore 12.8 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All HKI devices

HKI Camera, Ophthalmic, Ac-Powered: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HKI

4in 2025

2007: 22008: 52009: 112010: 62011: 72012: 52013: 72014: 42016: 42017: 22018: 62019: 42020: 52021: 42022: 12023: 52024: 32025: 42026 (partial year): 2
2007high 11 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HKI

167in 2025

2008: 29 days median2009: 104 days median2010: 140 days median2011: 160 days median2012: 179 days median2013: 141 days median2014: 135 days median2016: 146 days median2018: 71 days median2019: 73 days median2020: 182 days median2021: 155 days median2023: 259 days median2024: 28 days median2025: 167 days median
2007high 259 (2023) · low 28 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HKI

1in 2018

2012: 12016: 12017: 12018: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HKI

1in 2023

2007: 32008: 12009: 12012: 22013: 222014: 32015: 32016: 662017: 202018: 142020: 52021: 32022: 12023: 1
2007high 66 (2016) · low 0 (2010)2025

MAUDE reports naming product code HKI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
200852901
20091110401
2010614000
2011716000
2012517912
20137141022
2014413503
20150—03
20164146166
20172—120
2018671114
201947300
2020518205
2021415503
20221—01
2023525901
202432800
2025416700
20262—0—

What is it indicated for?

The RetinaDx Angiography System is intended for use by trained medical professionals (physicians, ophthalmic technicians, ophthalmic photographers or others with similar training) in a medical office, hospital or other medical setting. It is indicated when a medical professional suspects a patient could have damage or disease of the retina. It is used to take photographs of the patient's retina, which are then studied by the medical professional to get…

Read the full statement (115 words)

The RetinaDx Angiography System is intended for use by trained medical professionals (physicians, ophthalmic technicians, ophthalmic photographers or others with similar training) in a medical office, hospital or other medical setting. It is indicated when a medical professional suspects a patient could have damage or disease of the retina. It is used to take photographs of the patient's retina, which are then studied by the medical professional to get additional information about the retina to consider in his or her efforts to decide on a diagnosis and treatment plan. The RetinaDx system can be used with any patient of any age or condition who is able to sit still enough to have the photographs taken.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K003236: Retinadx.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K003236

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Page last updated Nov 3, 2026